Dr. Joseph Ladapo and MAHA (Podcast)
A rare interview with the fascinating Florida Surgeon General Dr. Joseph Ladapo, who hopes to play a role in the new Trump administration to Make America Healthy Again. Listen Below:
health
CDC recommends lowering age for pneumococcal vaccine to 50
The following information is from CDC. The Centers for Disease Control and Prevention (CDC) announced a new recommendation to lower the age for pneumococcal vaccination from 65 to 50 years old. This change, endorsed by CDC Director Mandy Cohen, follows
CDC recommends lowering age for pneumococcal vaccine to 50 Read More »
(Watch) Update: Alzheimer’s Drugs
An update to our reporting on two recently-approved Alzheimer’s drugs: aducanumab and Lecanemab. FDA advisers and many independent watchdogs said there’s no good evidence the hugely expensive shots make a meaningful difference, and they could cause serious side effects. But
The Case Against Dr. Kirk Moore (Podcast)
Dr. Kirk Moore is a medical doctor and plastic surgeon who gave kids blanks instead of Covid shots, at their parents’ request, and issued Covid vaccine cards to people who chose not to get vaccinated. Now he faces prison time.
(STUDY)Â Pfizer, Moderna Covid shots linked to acute heart disease risk
The following is from Children’s Health Defense. Conducted by a South Korean team, the study analyzed health data from over 3.35 million vaccinated individuals. Researchers specifically looked at cardiac events, including acute cardiac injury, acute myocarditis, acute pericarditis, cardiac arrest, and cardiac arrhythmia, in
(STUDY) Pfizer, Moderna Covid shots linked to acute heart disease risk Read More »
CDC pushes for second 2024-25 Covid shot for seniors and vulnerable
The following is from the CDC. The CDC has recommended that people aged 65 and older, as well as those who are moderately or severely immunocompromised, consider receiving a second dose of the 2024-2025 COVID-19 vaccine. The suggested time for
CDC pushes for second 2024-25 Covid shot for seniors and vulnerable Read More »
Patients in Alzheimer’s Drug Trials Not Told About Risks
The following information is from Public Citizen. Public Citizen, a nonprofit consumer advocacy organization, is calling for federal officials to investigate troubling practices in recent Alzheimer’s disease drug trials. A New York Times report reveals that participants in trials for two drugs—lecanemab
Patients in Alzheimer’s Drug Trials Not Told About Risks Read More »
